9 patents currently held
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Apr 2029. from the record
Of the 3 now held by other companies, 2 name Biovie Inc. as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Apr 2029
Next term end
4
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2031 · High confidence
Also notable
Ends Apr 2030 · High confidence
Also notable
Ends Sep 2031 · High confidence
Drug Identification and Treatment Method
US 8,354,396
Renewed at every maintenance window since the 2013 grant; no more fees are due before its term ends in 2031.
Solid State Forms of a Pharmaceutical
US 8,252,947
The largest patent family in this portfolio, 9 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Pharmaceutical Solid State Forms
US 8,518,922
The largest patent family in this portfolio, 5 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Formerly held, still cited
Notable
Ends Apr 2029 · High confidence
The largest patent family in this portfolio, 9 related applications, renewed at every maintenance window due so far. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
now held by Biovie Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 20, 2027The maintenance fee for Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related COMPOUNDS-2 (US 9,163,059) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Methods of Preparing Pharmaceutical Solid State Forms (US 9,314,471) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Solid State Forms of a Pharmaceutical | 4 in force | to Apr 2030 |
| Pharmaceutical Solid State Forms | 2 in force | to Sep 2031 |
| Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds | 2 in force | to Nov 2030 |
| Drug Identification and Treatment Method | 1 in force | to Jul 2031 |
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,850,271 | Crystalline solvate forms of a pharmaceutical In force · High confidence | In force | High confidence | |
| US 9,877,972 | Treatment Methods Using Pharmaceutical Solid State Forms In force · High confidence | In force | High confidence | |
| US 10,995,112 | Crystalline Solvate Forms of a Pharmaceutical In force · High confidence | In force | High confidence | |
| US 9,163,059 | Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related COMPOUNDS-2 In force · High confidence | In force | High confidence | |
| US 9,314,471 | Methods of Preparing Pharmaceutical Solid State Forms In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,252,947 | Solid State Forms of a Pharmaceutical In force · High confidence | In force | High confidence | |
| US 8,309,746 | Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds In force · High confidence | In force | High confidence | |
| US 8,354,396 | Drug Identification and Treatment Method In force · High confidence | In force | High confidence | |
| US 8,518,922 | Pharmaceutical Solid State Forms In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 3 patents in force now held by others · 30 patents ended · 52 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.